Zhao Yue, Zhang Yang, Huang Tianfeng, Ding Yinyin, Tao Yongzhong, Gao Ju
Graduate School, Dalian Medical University, Dalian 116044, Liaoning, China.
Department of Anesthesiology, Northern Jiangsu People's Hospital (Northern Jiangsu People's Hospital Affiliated to Yangzhou University), Yangzhou 225001, Jiangsu, China. Corresponding author: Gao Ju, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):404-409. doi: 10.3760/cma.j.cn121430-20230911-00774.
To evaluate the effect of transnasal humidified rapid insufflation ventilatory exchange (THRIVE) on regional cerebral oxygen saturation (rScO) during induction of general anesthesia in patients undergoing traumatic brain injury (TBI) emergency surgery.
A prospective randomized controlled trial was conducted. The TBI emergency general anesthesia patients who underwent intracranial hematoma removal surgery at the Northern Jiangsu People's Hospital from January to July in 2023 were enrolled. The patients were divided into a conventional mask ventilation group and a THRIVE group using a random number table method. The patients in the conventional mask ventilation group were anesthetized and induced to pre oxygenate without positive pressure ventilation in the front mask for 10 minutes, with an oxygen flow rate of 8 L/min and an fraction of inspired oxygen (FiO) of 1.00. After anesthesia induction for about 90 s, tracheal intubation was performed after the muscle relaxant took effect (patient's jaw muscle was relaxed). The patients in the THRIVE group were pre oxygenated with THRIVE for 10 minutes, with an oxygen flow rate of 30 L/min and a FiO of 1.00. During anesthesia induction, the oxygen flow rate was increased to 50 L/min, and anesthesia induction medication was used. The lower jaw of patient was supported with both hands to maintain airway patency, and the patient's mouth was kept closed throughout the process. After the muscle relaxant took effect (the patient's jaw muscle was relaxed), tracheal intubation was performed. At the time of patient entering the operating room, 10 minutes of pre oxygenation, and immediately after successful intubation, rScO was measured on the surgical and non-surgical sides. At the same time, ultrasound was used to measure the cross-sectional area (CSA) of the gastric antrum and arterial blood gas analysis was performed. The partial pressure of end-tidal carbon dioxide (PCO) during the first mechanical ventilation after successful tracheal intubation, the incidence of hypoxemia [pulse oxygen saturation (SpO) < 0.95] during tracheal intubation, as well as prognostic indicators such as the length of intensive care unit (ICU) stay, total length of hospital stay, and Glasgow outcome scale (GOS) score at discharge were recorded.
During the study period, a total of 70 TBI patients underwent emergency general anesthesia surgery, of which 2 patients died postoperatively, 2 patients were unable to cooperate with closed mouth breathing, and 3 patients had poor ultrasound image acquisition in the gastric antrum, all of whom were excluded. A total of 63 patients were ultimately enrolled, including 32 in the conventional mask ventilation group and 31 in the THRIVE group. There were no statistically significant differences in gender, age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, Glasgow coma scale (GCS) score, optic nerve sheath diameter (ONSD), baseline vital signs, fasting situation, anesthesia time, surgical time, and intraoperative blood loss between the patients in the two groups, indicating comparability. When entering the operating room, there was no statistically significant difference in rScO on the surgical and non-surgical sides, and blood gas analysis indexes arterial partial pressure of oxygen (PaO) and arterial partial pressure of carbon dioxide (PaCO) between the patients in the two groups. When pre oxygenated for 10 minutes, both the surgical and non-surgical sides rScO levels in the THRIVE group were significantly higher than those in the conventional mask ventilation group (surgical side: 0.709±0.036 vs. 0.636±0.028, non-surgical side: 0.791±0.016 vs. 0.712±0.027, both P < 0.01), and the PaO was significantly increased [mmHg (1 mmHg ≈ 0.133 kPa): 450.23±60.99 vs. 264.88±49.33, P < 0.01], PaCO was significantly reduced (mmHg: 37.81±3.65 vs. 43.59±3.76, P < 0.01), and the advantage continues tilled immediately after successful intubation. There was no statistically significant difference in CSA at each time point of ultrasound examination between the two groups. Compared with the conventional mask ventilation group, the patients in the THRIVE group showed a significant decrease in PCO during the first mechanical ventilation after successful tracheal intubation (mmHg: 43.10±2.66 vs. 49.22±3.31, P < 0.01), and the incidence of hypoxemia during tracheal intubation was also significantly reduced [0% (0/31) vs. 28.12% (9/32), P < 0.01]. In terms of prognostic indicators, there was no statistically significant difference in the length of ICU stay and total length of hospital stay between the patients in the conventional mask ventilation group and the THRIVE group [length of ICU stay (days): 10 (9, 10) vs. 10 (9, 11), total length of hospital stay (days): 28.00 (26.00, 28.75) vs. 28.00 (27.00, 29.00), both P > 0.05]. However, the proportion of patients in the THRIVE group with a good prognosis at discharge (GOS score > 3) was significantly higher than that in the conventional mask ventilation group [35.5% (11/31) vs. 12.5% (4/32), P < 0.05].
THRIVE can significantly increase rScO during anesthesia induction in TBI emergency surgery patients and improve their neurological function prognosis.
评估经鼻湿化快速充气通气交换(THRIVE)对创伤性脑损伤(TBI)急诊手术患者全身麻醉诱导期间局部脑氧饱和度(rScO)的影响。
进行一项前瞻性随机对照试验。纳入2023年1月至7月在苏北人民医院接受颅内血肿清除手术的TBI急诊全身麻醉患者。采用随机数字表法将患者分为传统面罩通气组和THRIVE组。传统面罩通气组患者在麻醉诱导前进行预充氧,不进行正面罩正压通气,持续10分钟,氧流量为8 L/分钟,吸入氧分数(FiO)为1.00。麻醉诱导约90秒后,在肌肉松弛剂起效(患者下颌肌肉松弛)后进行气管插管。THRIVE组患者采用THRIVE进行预充氧10分钟,氧流量为30 L/分钟,FiO为1.00。在麻醉诱导期间,将氧流量增加至50 L/分钟,并使用麻醉诱导药物。用双手支撑患者下颌以保持气道通畅,在整个过程中患者口腔保持闭合。在肌肉松弛剂起效(患者下颌肌肉松弛)后进行气管插管。在患者进入手术室时、预充氧10分钟时以及成功插管后立即,测量手术侧和非手术侧的rScO。同时,使用超声测量胃窦横截面积(CSA)并进行动脉血气分析。记录气管插管成功后首次机械通气期间的呼气末二氧化碳分压(PCO)、气管插管期间低氧血症的发生率[脉搏血氧饱和度(SpO)<0.95],以及诸如重症监护病房(ICU)住院时间、总住院时间和出院时格拉斯哥预后评分(GOS)等预后指标。
在研究期间,共有70例TBI患者接受急诊全身麻醉手术,其中2例术后死亡,2例无法配合闭口呼吸,3例胃窦超声图像采集不佳,均被排除。最终共纳入63例患者,其中传统面罩通气组32例,THRIVE组31例。两组患者在性别、年龄、体重指数(BMI)、美国麻醉医师协会(ASA)分级、格拉斯哥昏迷量表(GCS)评分、视神经鞘直径(ONSD)、基线生命体征、禁食情况、麻醉时间、手术时间和术中出血量方面无统计学显著差异,表明具有可比性。进入手术室时,两组患者手术侧和非手术侧的rScO以及血气分析指标动脉血氧分压(PaO)和动脉血二氧化碳分压(PaCO)无统计学显著差异。预充氧10分钟时,THRIVE组手术侧和非手术侧的rScO水平均显著高于传统面罩通气组(手术侧:0.709±0.036对0.636±0.028,非手术侧:0.791±0.016对0.712±0.027,均P<0.01),且PaO显著升高[mmHg(1 mmHg≈0.133 kPa):450.23±60.99对264.88±49.33,P<0.01],PaCO显著降低(mmHg:37.81±3.65对43.59±3.76,P<0.01),且该优势持续至成功插管后即刻。两组超声检查各时间点的CSA无统计学显著差异。与传统面罩通气组相比,THRIVE组患者在气管插管成功后首次机械通气期间的PCO显著降低(mmHg:43.10±2.66对49.22±3.31,P<0.01),气管插管期间低氧血症的发生率也显著降低[0%(0/31)对28.12%(9/32),P<0.01]。在预后指标方面,传统面罩通气组和THRIVE组患者的ICU住院时间和总住院时间无统计学显著差异[ICU住院时间(天):10(9,10)对10(9,11),总住院时间(天):28.00(26.00,28.75)对28.00(27.00,29.00),均P>0.05]。然而,THRIVE组出院时预后良好(GOS评分>3)的患者比例显著高于传统面罩通气组[35.5%(11/31)对12.5%(4/32),P<0.05]。
THRIVE可显著提高TBI急诊手术患者麻醉诱导期间的rScO,并改善其神经功能预后。